Kori Wallace serves as the Vice President of Clinical Development for AbbVie Immunology, where she creates and implements the strategic vision for the organization's portfolio of assets ranging from pre-IND to post-marketing stages. With a dual background in clinical pediatrics and immunology research, Wallace is responsible for setting aggressive therapeutic area strategies that drive assets from early discovery through successful commercialization.